Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001233239 | SCV001405822 | uncertain significance | Neuroblastoma, susceptibility to, 3 | 2025-02-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser1038Trpfs*2) in the ALK gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in ALK cause disease. This variant is present in population databases (rs750796687, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with uterine cancer (PMID: 29625052). ClinVar contains an entry for this variant (Variation ID: 959821). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |